Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 31, Issue 9, Pages 4153-4167
Publisher
FASEB
Online
2017-06-08
DOI
10.1096/fj.201700063r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway
- (2016) Hui Yang et al. BIOCHEMICAL PHARMACOLOGY
- Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups
- (2016) Xudan Shi et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Sestrin2 induced by hypoxia inducible factor1 alpha protects the blood-brain barrier via inhibiting VEGF after severe hypoxic-ischemic injury in neonatal rats
- (2016) Xudan Shi et al. NEUROBIOLOGY OF DISEASE
- Cardiac-Specific Deletion of thePdha1Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress
- (2016) Wanqing Sun et al. TOXICOLOGICAL SCIENCES
- Sestrin2–AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity
- (2015) Kyuhwa Seo et al. CELLULAR SIGNALLING
- Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart
- (2015) Alex Morrison et al. FASEB JOURNAL
- Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury
- (2015) Yina Ma et al. THROMBOSIS AND HAEMOSTASIS
- Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains
- (2015) Hanseong Kim et al. Nature Communications
- Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction
- (2013) Jingying Wang et al. CIRCULATION
- Antithrombin is protective against myocardial ischemia and reperfusion injury
- (2013) J. Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Maintenance of Metabolic Homeostasis by Sestrin2 and Sestrin3
- (2012) Jun Hee Lee et al. Cell Metabolism
- Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress
- (2012) Chao Tong et al. FASEB JOURNAL
- Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart
- (2012) R. COSTA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells
- (2012) Toran Sanli et al. PLoS One
- AMPK in myocardial infarction and diabetes: the yin/yang effect
- (2012) Amr Moussa et al. Acta Pharmaceutica Sinica B
- Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice
- (2011) Alex Morrison et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction
- (2011) Nels Olson et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy
- (2011) Alex Morrison et al. BIOCHEMICAL PHARMACOLOGY
- A small molecule AMPK activator protects the heart against ischemia–reperfusion injury
- (2011) Agnes S. Kim et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling
- (2011) J. WANG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction
- (2010) Subat Turdi et al. AGING CELL
- Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
- (2010) Aslan T. Turer et al. AMERICAN JOURNAL OF CARDIOLOGY
- Stimulation of autophagy by the p53 target gene Sestrin2
- (2010) Maria Chiara Maiuri et al. CELL CYCLE
- Impaired Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Activation and Ischemic Recovery in the Senescent Heart
- (2010) Heng Ma et al. CIRCULATION
- Compensatory Increases in Nuclear PGC1 Protein Are Primarily Associated With Subsarcolemmal Mitochondrial Adaptations in ZDF Rats
- (2010) G. P. Holloway et al. DIABETES
- Stressin' Sestrins take an aging fight
- (2010) Andrei V. Budanov et al. EMBO Molecular Medicine
- Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies
- (2010) J. H. Lee et al. SCIENCE
- AMP-activated protein kinase: a core signalling pathway in the heart
- (2009) A. S. Kim et al. Acta Physiologica
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
- (2009) Bei B. Zhang et al. Cell Metabolism
- Role of sestrin2 in peroxide signaling in macrophages
- (2009) Silke Essler et al. FEBS LETTERS
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra
- (2008) Lawrence H. Young CIRCULATION
- Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
- (2008) Edward J. Miller et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started